Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia

Elisa Ten Hacken, Mariela Sivina, Ekaterina Kim, Susan O'Brien, William G. Wierda, Alessandra Ferrajoli, Zeev Estrov, Michael J. Keating, Thomas Oellerich, Cristina Scielzo, Paolo Ghia, Federico Caligaris-Cappio, Jan A. Burger

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The online version of this article contains supplemental material. BCR signaling is a central pathogenetic pathway in chronic lymphocytic leukemia (CLL). Most CLL cells express BCRs of IgM and IgD isotypes, but the contribution of these isotypes to functional responses remains incompletely defined.We therefore investigated differences between IgM and IgD signaling in freshly isolated peripheral blood CLL cells and in CLL cells cultured with nurselike cells, a model that mimics the lymph node microenvironment. IgM signaling induced prolonged activation of ERK kinases and promoted CLL cell survival, CCL3 and CCL4 chemokine secretion, and downregulation of BCL6, the transcriptional repressor of CCL3. In contrast, IgD signaling induced activation of the cytoskeletal protein HS1, along with F-actin polymerization, which resulted in rapid receptor internalization and failure to support downstream responses, including CLL cell survival and chemokine secretion. IgM and IgD receptor downmodulation, HS1 and ERK activation, chemokine secretion, and BCL6 downregulation were also observed when CLL cells were cocultured with nurselike cells. The Bruton's tyrosine kinase inhibitor ibrutinib effectively inhibited both IgM and IgD isotype signaling. In conclusion, through a variety of functional readouts, we demonstrate very distinct outcomes of IgM and IgD isotype activation in CLL cells, providing novel insight into the regulation of BCR signaling in CLL.

Original languageEnglish
Pages (from-to)2522-2531
Number of pages10
JournalJournal of Immunology
Volume197
Issue number6
DOIs
Publication statusPublished - Sep 15 2016

Fingerprint

Immunoglobulin D
B-Cell Chronic Lymphocytic Leukemia
Immunoglobulin M
Chemokines
Cell Survival
Down-Regulation
Chemokine CCL4
Chemokine CCL3
Cytoskeletal Proteins
Polymerization
Actins
Cultured Cells
Phosphotransferases
Lymph Nodes

ASJC Scopus subject areas

  • Immunology

Cite this

Ten Hacken, E., Sivina, M., Kim, E., O'Brien, S., Wierda, W. G., Ferrajoli, A., ... Burger, J. A. (2016). Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia. Journal of Immunology, 197(6), 2522-2531. https://doi.org/10.4049/jimmunol.1600915

Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia. / Ten Hacken, Elisa; Sivina, Mariela; Kim, Ekaterina; O'Brien, Susan; Wierda, William G.; Ferrajoli, Alessandra; Estrov, Zeev; Keating, Michael J.; Oellerich, Thomas; Scielzo, Cristina; Ghia, Paolo; Caligaris-Cappio, Federico; Burger, Jan A.

In: Journal of Immunology, Vol. 197, No. 6, 15.09.2016, p. 2522-2531.

Research output: Contribution to journalArticle

Ten Hacken, E, Sivina, M, Kim, E, O'Brien, S, Wierda, WG, Ferrajoli, A, Estrov, Z, Keating, MJ, Oellerich, T, Scielzo, C, Ghia, P, Caligaris-Cappio, F & Burger, JA 2016, 'Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia', Journal of Immunology, vol. 197, no. 6, pp. 2522-2531. https://doi.org/10.4049/jimmunol.1600915
Ten Hacken E, Sivina M, Kim E, O'Brien S, Wierda WG, Ferrajoli A et al. Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia. Journal of Immunology. 2016 Sep 15;197(6):2522-2531. https://doi.org/10.4049/jimmunol.1600915
Ten Hacken, Elisa ; Sivina, Mariela ; Kim, Ekaterina ; O'Brien, Susan ; Wierda, William G. ; Ferrajoli, Alessandra ; Estrov, Zeev ; Keating, Michael J. ; Oellerich, Thomas ; Scielzo, Cristina ; Ghia, Paolo ; Caligaris-Cappio, Federico ; Burger, Jan A. / Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia. In: Journal of Immunology. 2016 ; Vol. 197, No. 6. pp. 2522-2531.
@article{02d5e20a09964ad9a35b8bc746c69641,
title = "Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia",
abstract = "The online version of this article contains supplemental material. BCR signaling is a central pathogenetic pathway in chronic lymphocytic leukemia (CLL). Most CLL cells express BCRs of IgM and IgD isotypes, but the contribution of these isotypes to functional responses remains incompletely defined.We therefore investigated differences between IgM and IgD signaling in freshly isolated peripheral blood CLL cells and in CLL cells cultured with nurselike cells, a model that mimics the lymph node microenvironment. IgM signaling induced prolonged activation of ERK kinases and promoted CLL cell survival, CCL3 and CCL4 chemokine secretion, and downregulation of BCL6, the transcriptional repressor of CCL3. In contrast, IgD signaling induced activation of the cytoskeletal protein HS1, along with F-actin polymerization, which resulted in rapid receptor internalization and failure to support downstream responses, including CLL cell survival and chemokine secretion. IgM and IgD receptor downmodulation, HS1 and ERK activation, chemokine secretion, and BCL6 downregulation were also observed when CLL cells were cocultured with nurselike cells. The Bruton's tyrosine kinase inhibitor ibrutinib effectively inhibited both IgM and IgD isotype signaling. In conclusion, through a variety of functional readouts, we demonstrate very distinct outcomes of IgM and IgD isotype activation in CLL cells, providing novel insight into the regulation of BCR signaling in CLL.",
author = "{Ten Hacken}, Elisa and Mariela Sivina and Ekaterina Kim and Susan O'Brien and Wierda, {William G.} and Alessandra Ferrajoli and Zeev Estrov and Keating, {Michael J.} and Thomas Oellerich and Cristina Scielzo and Paolo Ghia and Federico Caligaris-Cappio and Burger, {Jan A.}",
year = "2016",
month = "9",
day = "15",
doi = "10.4049/jimmunol.1600915",
language = "English",
volume = "197",
pages = "2522--2531",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "6",

}

TY - JOUR

T1 - Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia

AU - Ten Hacken, Elisa

AU - Sivina, Mariela

AU - Kim, Ekaterina

AU - O'Brien, Susan

AU - Wierda, William G.

AU - Ferrajoli, Alessandra

AU - Estrov, Zeev

AU - Keating, Michael J.

AU - Oellerich, Thomas

AU - Scielzo, Cristina

AU - Ghia, Paolo

AU - Caligaris-Cappio, Federico

AU - Burger, Jan A.

PY - 2016/9/15

Y1 - 2016/9/15

N2 - The online version of this article contains supplemental material. BCR signaling is a central pathogenetic pathway in chronic lymphocytic leukemia (CLL). Most CLL cells express BCRs of IgM and IgD isotypes, but the contribution of these isotypes to functional responses remains incompletely defined.We therefore investigated differences between IgM and IgD signaling in freshly isolated peripheral blood CLL cells and in CLL cells cultured with nurselike cells, a model that mimics the lymph node microenvironment. IgM signaling induced prolonged activation of ERK kinases and promoted CLL cell survival, CCL3 and CCL4 chemokine secretion, and downregulation of BCL6, the transcriptional repressor of CCL3. In contrast, IgD signaling induced activation of the cytoskeletal protein HS1, along with F-actin polymerization, which resulted in rapid receptor internalization and failure to support downstream responses, including CLL cell survival and chemokine secretion. IgM and IgD receptor downmodulation, HS1 and ERK activation, chemokine secretion, and BCL6 downregulation were also observed when CLL cells were cocultured with nurselike cells. The Bruton's tyrosine kinase inhibitor ibrutinib effectively inhibited both IgM and IgD isotype signaling. In conclusion, through a variety of functional readouts, we demonstrate very distinct outcomes of IgM and IgD isotype activation in CLL cells, providing novel insight into the regulation of BCR signaling in CLL.

AB - The online version of this article contains supplemental material. BCR signaling is a central pathogenetic pathway in chronic lymphocytic leukemia (CLL). Most CLL cells express BCRs of IgM and IgD isotypes, but the contribution of these isotypes to functional responses remains incompletely defined.We therefore investigated differences between IgM and IgD signaling in freshly isolated peripheral blood CLL cells and in CLL cells cultured with nurselike cells, a model that mimics the lymph node microenvironment. IgM signaling induced prolonged activation of ERK kinases and promoted CLL cell survival, CCL3 and CCL4 chemokine secretion, and downregulation of BCL6, the transcriptional repressor of CCL3. In contrast, IgD signaling induced activation of the cytoskeletal protein HS1, along with F-actin polymerization, which resulted in rapid receptor internalization and failure to support downstream responses, including CLL cell survival and chemokine secretion. IgM and IgD receptor downmodulation, HS1 and ERK activation, chemokine secretion, and BCL6 downregulation were also observed when CLL cells were cocultured with nurselike cells. The Bruton's tyrosine kinase inhibitor ibrutinib effectively inhibited both IgM and IgD isotype signaling. In conclusion, through a variety of functional readouts, we demonstrate very distinct outcomes of IgM and IgD isotype activation in CLL cells, providing novel insight into the regulation of BCR signaling in CLL.

UR - http://www.scopus.com/inward/record.url?scp=84988960544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988960544&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1600915

DO - 10.4049/jimmunol.1600915

M3 - Article

AN - SCOPUS:84988960544

VL - 197

SP - 2522

EP - 2531

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 6

ER -